"The U.S. Food and Drug Administration today approved Hysingla ER (hydrocodone bitartrate), an extended-release (ER) opioid analgesic to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternat"...
NORCOÃ? is indicated for the relief of moderate to moderately severe pain.
DOSAGE AND ADMINISTRATION
Dosage should be adjusted according to the severity of the pain and the response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose related.
The usual adult dosage is one or two tablets every four to six hours as needed for pain.
NorcoÃ? 5/325 tablets (Hydrocodone Bitartrate and Acetaminophen Tablets USP, 5 mg/325 mg) contain hydrocodone bitartrate 5 mg and acetaminophen 325 mg. They are supplied as white with orange specks, capsule-shaped, bisected tablets, debossed Watson on one side and 913 on the other side, in bottles of 100 tablets, NDC 52544-913-01, in bottles of 500 tablets, NDC 52544-913-05, and in hospital unit-dose cartons of 100 tablets (25 tablets x 4 cards), NDC 52544-913-48.
Storage: Store at controlled room temperature 15°-30°C (59°-86°F). Dispense in a tight, light-resistant container with a child-resistant closure. A Schedule CIII Narcotic.
Last reviewed on RxList: 3/24/2006
This monograph has been modified to include the generic and brand name in many instances.
Additional Norco 5/325 Information
Norco 5/325 - User Reviews
Norco 5/325 User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Chronic Pain/Back Pain
Find tips and advances in treatment.